Policy changes Backwork has recorded, newest first. The most recent change on record is from October 24, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
86,510 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Chemodenervation With Botulinum Toxin | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Chelation Therapy FOR OFF Label Uses | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Cetuximab Erbitux | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Cervical Fusions | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Certolizumab Cimzia | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Cerliponase Alfa Brineura | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Cerebral Oxygenation Monitoring Using Near Infrared Spectroscopy Nirs | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Casimersen Amondys 45 | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Carfilzomib Kyprolis 2 | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Cardiac Rehabilitation Programs Phase II Outpatient | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Cardiac Monitors | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Cardiac Applications OF Positron Emission Tomography Scanning | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Cardiac Ablation Procedures | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | CT Virtual Colonoscopy | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Burosumab Crysvita | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Bulking Agents FOR THE Treatment OF Urinary Stress Incontinence AND Vesicoureteral Reflux | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Bronchial Thermoplasty | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Brexanolone Zulresso | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Brentuximab Vedotin Adcetris | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Breast MRI | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Breast Ductal Lavage AND Fiberoptic Ductoscopy | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Braces AND Supports | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Bone Turnover Markers FOR Diagnosis AND Management OF Osteoporos | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Bone Mineral Density Studies | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Blinatumomab Blincyto | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Biomarkers IN Risk Assessment AND Management OF Cardiovascular Disease | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Biofeedback 2 | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Bioengineered Skin AND Soft Tissue Substitutes | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Bezlotoxumab Zinplava | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Bevacizumab Avastin AND Bevacizumab Biosimilars | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Benbendamustine Treanda Bendeka Belrapzo | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Belimumab Benlysta | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Belatacept Nulojix | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Belantamab Mafodotin Blenrep | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Beds Accessories AND Related Items | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Obesity | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Bamlanivimab | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Balloon Ostial Dilation OF THE Sinus AND Implantable Sinus Stents | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Axial Lumbosacral Interbody Fusion | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Autonomic Nervous System Function Testing | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Autologous Chondrocyte Implantation FOR Focal Articular Cartilage Lesions | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Autologous Cellular Immunotherapy FOR Prostate Cancer | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Autografts AND Allografts IN THE Treatment OF Focal Articular Cartilage Lesions | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Assisted Reproductive Technology | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Artificial Intervertebral Disc Replacement | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Artificial Hearts AND Ventricular Assist Devices | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Arthrocentesis OR Needling OF Bursa | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Aqueous Shunts AND Stents FOR Glaucoma | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Apostherapy System | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Ankle Foot Knee Ankle Foot Orthosis | New policy |